` BIOBV (Biohit Oyj) vs DAX Index Comparison - Alpha Spread

BIOBV
vs
DAX Index

Over the past 12 months, BIOBV has outperformed DAX Index, delivering a return of 26% compared to the DAX Index's 22% growth.

Stocks Performance
BIOBV vs DAX Index

Loading

Performance Gap
BIOBV vs DAX Index

Sign Up to see
Performance Gap
Sign In
Sign Up

Performance By Year
BIOBV vs DAX Index

Loading
BIOBV
DAX Index
Add Stock

Competitors Performance
Biohit Oyj vs Peers

DAX Index
BIOBV
ABT
ISRG
BSX
SYK
Add Stock

Biohit Oyj
Glance View

Market Cap
38.7m EUR
Industry
Health Care

Biohit Oyj engages in the development, manufacture, and market of diagnostic tests and analysis systems. The company is headquartered in Helsinki, Etela-Suomen. The firm operates one business segment, named Diagnostics. The Diagnostics segment offers solutions for the early diagnosis and prevention of gastrointestinal diseases. The company provides blood-sample examination based on GastroPanel for the diagnosis of stomach illnesses and associated risks, quick tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, as well as the ColonView examination for the early detection of fecal occult intestinal bleeding, which indicates a risk of colorectal cancer. The Company’s products are used in hospitals, healthcare centers and research institutions. The company operates primarily in Europe and Asia. Furthermore, the Company is a parent of Biohit Healthcare Ltd, Biohit Healthcare Srl, Oy Finio Ab, and Vantaan Hienomekano Oy, among others.

BIOBV Intrinsic Value
HIDDEN
Show
Back to Top